register

News & Trends - MedTech & Diagnostics

New J&J cervical spine system to reduce procedural complexity and surgical costs

Health Industry Hub | November 25, 2019 |

The Johnson & Johnson Medical Devices Companies announced that DePuy Synthes has launched the SYMPHONY Occipito-Cervico-Thoracic (OCT) System, expanding its offering for the surgical treatment of conditions in the neck and upper back.

The SYMPHONY System includes a differentiated offering of instruments and implants designed for stabilisation of the spine in patients undergoing Posterior Cervical Fusion surgery. The announcement was made at the 47th annual Cervical Spine Research Society (CSRS) meeting.

Guided by research conducted in association with the International Spine Study Group, the SYMPHONY System is designed to improve surgeon experience in four key areas: fixation, alignment, targeting and extensions. The range of instrumentation offers options for surgeons to choose from and is compatible with navigation software to aid in targeting in challenging anatomy.

“The most interesting aspect of the SYMPHONY System is its ability to address highly complex needs that we face at the front lines of cervical spine surgery,” said Dr Christopher Ames, Spine Surgeon. “It also takes into account ways to create efficiencies for healthcare systems, making it a truly comprehensive offering.”

The SYMPHONY System was designed to improve fixation in patients with suboptimal bone quality, to address a potential cause of screw failure which may lead to revision surgery. By enabling crossing of the cervical to thoracic junction with one system, the SYMPHONY System reduces the number of instrument trays from six to two, which may provide cost savings in processing and sterilisation as well.1

The system combines the benefits of two market-leading posterior cervical systems—the SYNAPSE OCT System and MOUNTAINEER OCT System—uniting many of the patented features of those brands and building on their proven instrumentation.

You may also like QLD researchers discover blood test for deadly ocular melanoma

Register FREE to receive the latest news, innovations and insights from Health Industry Hub; the only one-stop-hub connecting Australia’s Pharma, MedTech and Biotech industry professionals and its key stakeholders.


News & Trends - MedTech & Diagnostics

Parliament passes lung cancer legislation

Parliament passes lung cancer legislation

Health Industry Hub | May 17, 2024 |

MedTech & Diagnostics News: Lung cancer is the leading cause of cancer death and is responsible for almost one in […]

More


News & Trends - Pharmaceuticals

Senator Ruston criticises Budget's lack of 'real seamanship' in tackling pressing healthcare challenges

Senator Ruston criticises Budget’s lack of ‘real seamanship’ in tackling pressing healthcare challenges

Health Industry Hub | May 17, 2024 |

Pharma News: Senator Anne Ruston, Shadow Health Minister, was warmly welcomed at the Post-Budget event held in Parliament House yesterday […]

More


News & Trends - MedTech & Diagnostics

Baxter announces branding for spin-off kidney care business

Baxter announces branding for spin-off kidney care business

Health Industry Hub | May 17, 2024 |

MedTech & Diagnostics News: Baxter has unveiled the mission and logo for its forthcoming kidney care and acute therapies company, […]

More


ESG

Health and climate strategy: All talk, no budget

Health and climate strategy: All talk, no budget

Health Industry Hub | May 16, 2024 |

ESG: The Federal Budget has sparked disappointment among health professionals for its lack of attention to addressing the escalating impacts […]

More


This content is copyright protected. Please subscribe to gain access.